Navigation Links
Arthritis sufferers fund arthritis research
Date:2/19/2008

The Queensland and Northern New South Wales Lions Medical Research Foundation, long time supporters of the Brisbane research community, have confirmed funding of $1.2 million for scientists at UQ's Diamantina Institute.

Dr Gethin Thomas will be the inaugural recipient of the $300,000 three-year fellowship, which will fund his research investigating the causes of ankylosing spondylitis (AS).

This is a form of arthritis affecting the spine resulting in joint fusion and immobility, and osteoporosis, a disease characterised by bone loss and frequent fracture.

This funding will enable us to focus on our longer-term goals of identifying the underlying causes of these diseases and developing new drugs and therapies, Dr Thomas said.

There is an urgent need for new therapies in these diseases that will enable reversal of disease damage.

The current therapies can only prevent progression of AS and osteoporosis but cannot repair already damaged bones and joints.

Unfortunately sufferers are frequently not diagnosed until fracture or loss of mobility by which time degeneration of the bones or joints is already significant.

Irene Dunning, Lions Foundation Chairman, said she was pleased Dr Thomas had received the first installment of the new Fellowship.

I think it's good to be supporting something which will potentially help a lot of Lions members," she said.

Osteoporosis and arthritis are diseases that affect many Lions members and their families and friends.

Lions members will further contribute to the research by volunteering as participants in the studies providing a valuable resource for our research efforts and creating a mutually beneficial synergy.


'/>"/>

Contact: Penny Robinson
penny.robinson@uq.edu.au
61-733-659-723
Research Australia
Source:Eurekalert

Page: 1

Related medicine news :

1. Study Suggests Glucosamine Wont Ease Hip Arthritis
2. Gene Linked to Inflammatory Arthritis Also Raises Heart Risks
3. Rheumatoid arthritis sends many into early retirement
4. Depression not discussed during rheumatoid arthritis doctor visits
5. The HLA-DRB1 gene and premature death in rheumatoid arthritis
6. Newer Rheumatoid Arthritis Drugs Lower Production of B Cells
7. Popular arthritis drug may disrupt heart rhythm, UB research finds
8. Exercise Program Eases Arthritis
9. A new view of drugs used to treat rheumatoid arthritis
10. Genes Linked to Height Also Tied to Osteoarthritis Risk
11. Modified-Release Prednisone May Ease Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Dr. Parsa Mohebi M.D. has ... hair loss achieve great results in hair transplantation. One ... Transplant , an FUE method that harvests facial hair for ... method lets patients whose hair loss classification is 5 and ... is a great alternative for those advanced hair loss patients ...
(Date:8/29/2014)... Highly regarded audiologist , Dr. Mary Ann Larkin has ... four reports are titled:, , Revealing the Truth ... , The Top 5 Things You Should Know Before ... in Children , Dr. Mary Anne Larkin choose to ... confusion and misinformation about each them. The reports are available ...
(Date:8/29/2014)... 2014 Pursuing its deepest desires to ... unveil a stunning new design that promises to redefine ... highly notable surrogacy platform has witnessed a 42 percent ... visitors a month, the FindSurrogateMother.com community is formed by ... common goal — the precious gift of life. , ...
(Date:8/29/2014)... 29, 2014 (HealthDay News) -- If you have bunions, taking ... treatment later, an expert says. A bunion is a ... when bone or tissue moves out of place and extends ... can cause debilitating pain and may require surgery to correct, ... Medical Center in Freehold, N.J. To prevent bunions, avoid ...
(Date:8/29/2014)... August 29, 2014 - Despite US Preventive Services ... are many barriers, several of which may be ameliorated ... researchers at NYU Langone Medical Center published online August ... Medicine ( JGIM ). , David Levine, MD, ... Internal Medicine at NYU Langone, and colleagues found that ...
Breaking Medicine News(10 mins):Health News:Advanced Hair Loss Patients Can Now Qualify for Hair Transplants Using Facial Donor Hair 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 3Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Take Steps to Control Bunions 2Health News:Options for weight loss your primary care doctor might not know about 2
... Than 1,500 YMCAs Get Their Communities Moving During Week-Long Event; ... YMCAs Aim to Keep Communities Active Year-Round, WASHINGTON, ... logged during "America On the Move Week with the YMCA" ... More than 1,500 YMCAs nationwide reached out to their ...
... With an eye on curing diabetes, scientists at Washington ... transplanted embryonic pig pancreatic cells destined to produce insulin ... for risky immune suppression drugs that prevent rejection. , ... earliest stages of developing into pancreatic tissues. Within several ...
... it instead of traditional immune globulin injection , , THURSDAY, ... hepatitis A with the hepatitis A vaccine is as ... of immune globulin, a new study found. , Based ... and Prevention,s Advisory Committee on Immunization Practices now recommends ...
... Union Urges Congress to Enact HR 1174 (Murphy) ... WASHINGTON, Oct. 18 A new study that,estimates ... virulent,antibiotic-resistant infection acquired mostly in the hospital underscores,the ... patient infection,rates, according to Consumers Union, the nonprofit ...
... device evaluated in cadaver by leading spine ... ... CoreSpine Technologies LLC, an,emerging spinal device company located in Minneapolis, Minnesota ... first product in development is a complete nucleus removal,device that seeks ...
... Conseco, Inc. (NYSE:,CNO) will report results for the ... 31, 2007. The company will host a conference call ... November 1, 2007. The web cast of the ... the company,s website as follows:, http://investor.conseco.com . Listeners should ...
Cached Medicine News:Health News:YMCA's Activate America(R) Motivates More Than 1.3 Million People to Take 8 Billion Steps Toward a Healthier Lifestyle During 'America On the Move Week with the YMCA' 2Health News:YMCA's Activate America(R) Motivates More Than 1.3 Million People to Take 8 Billion Steps Toward a Healthier Lifestyle During 'America On the Move Week with the YMCA' 3Health News:YMCA's Activate America(R) Motivates More Than 1.3 Million People to Take 8 Billion Steps Toward a Healthier Lifestyle During 'America On the Move Week with the YMCA' 4Health News:Cross-species transplant in rhesus macaques is step toward diabetes cure for humans 2Health News:Cross-species transplant in rhesus macaques is step toward diabetes cure for humans 3Health News:Hepatitis A Vaccine Best Bet to Treat Virus 2Health News:Hepatitis A Vaccine Best Bet to Treat Virus 3Health News:Alarming MRSA Infection Rates Underscore Need for Public Reporting of Hospital-Acquired Infections 2Health News:Alarming MRSA Infection Rates Underscore Need for Public Reporting of Hospital-Acquired Infections 3Health News:Initial Evaluation of New Nucleus Removal Device Provides Promising Results 2
(Date:8/29/2014)... PITTSBURGH , Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage ... at the Australian and New Zealand Forensic Science ... Forensic Sciences in Adelaide, Australia ... discussion concerning the advancements that hyperspectral imaging can ... Jeffrey Beckstead , Director of Product Development ...
(Date:8/29/2014)... 29, 2014  In part four of ... hospital pharmacy as a strategic asset, Mary Baxter, ... for Cardinal Health,s Innovation Delivery Solutions business, discusses how ... both hospitals and patients. "Every hospital pharmacist ... of their job in a value-based healthcare world," Baxter ...
(Date:8/29/2014)... 2014  Pacific Medical Data Solutions is excited to ... . The main website, along with the site,s blog, ... services and content relevant to the medical billing industry. ... viewers can now better understand how PMDS products help ... create a more visible platform about medical billing best ...
Breaking Medicine Technology:ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4PMDS Announces New Website 2
... AMSTERDAM, April 18, 2012  Leading events organiser UBM Live ... the global UBM Pharma Portfolio, CPhI Southeast Asia (SEA) 2012. ... International Expo in Indonesia, CPhI SEA is the first trade ... the pharmaceutical ingredient sector in the ASEAN region. ...
... -   Retrospective sub-analyses from ADVANCE, ... European Association for the Study of the Liver (EASL) 2012 ... new data for INCIVO (telaprevir) from Phase 3 retrospective sub-analyses ... the Study of the Liver (EASL) in Barcelona.  The data ...
Cached Medicine Technology:Leading Pharma Ingredients Event Debuts in Growing ASEAN Market 2Leading Pharma Ingredients Event Debuts in Growing ASEAN Market 3INCIVO® (Telaprevir) SVR Rates Unaffected by Ribavirin Dose Reduction in Treatment Naïve and Previously Treated Patients With Genotype-1 Chronic HCV 2INCIVO® (Telaprevir) SVR Rates Unaffected by Ribavirin Dose Reduction in Treatment Naïve and Previously Treated Patients With Genotype-1 Chronic HCV 3INCIVO® (Telaprevir) SVR Rates Unaffected by Ribavirin Dose Reduction in Treatment Naïve and Previously Treated Patients With Genotype-1 Chronic HCV 4INCIVO® (Telaprevir) SVR Rates Unaffected by Ribavirin Dose Reduction in Treatment Naïve and Previously Treated Patients With Genotype-1 Chronic HCV 5INCIVO® (Telaprevir) SVR Rates Unaffected by Ribavirin Dose Reduction in Treatment Naïve and Previously Treated Patients With Genotype-1 Chronic HCV 6INCIVO® (Telaprevir) SVR Rates Unaffected by Ribavirin Dose Reduction in Treatment Naïve and Previously Treated Patients With Genotype-1 Chronic HCV 7
... standard trial frames. They are made of optical quality ... box. There are two sets available providing a full ... is that a patient can wear the prism with ... the patient to adapt to the use of the ...
... C Dermatome - reaching a new evolutionary plateau. ... to operate in the pulse mode, or to ... entire instrument and hose assembly is autoclavable and ... 2-, 3-, or 4-inch widths. Simply select the ...
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates....
BD Visitec IOL Manipulator (Fenzl), blunt tip angled 45, 12.0 mm from end, fits 0.20 mm diameter holes and larger (3/bx, 1 bx/ca). For positioning intraocular lenses. Sure grip handles hand ridge ind...
Medicine Products: